TP53 and cancer: At the molecular level, rCAFs up-regulate PI3K/AKT/p65 driven cell survival pathway and TGFα production, which in turn protect cancer cells from chemotherapy-induced cell death by activating the EGFR/Src/STAT3 survival pathway and repressing the p53/caspase-3 driven apoptosis.